Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

Clinical trial NCT00238121 · COMPLETED

Trial details

NCT number: NCT00238121
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Sarcoma Stage III Uterine Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma

Start date: 2005-02-01
Primary completion: 2010-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.